Animal study · Supplements / medicine · 19 Oct 2026
In mice on a high-salt diet, a soy phospholipid fraction lowered blood pressure and improved object memory
Source: Fujita Health University / Neurochemistry International
What the research found
Study (mice). Hisayoshi Kubota, Akihiro Mouri, and colleagues at Fujita Health University, with Kazuhiro Kagotani of Tsuji Oil Mills, report in Neurochemistry International (2026; 197:106184; DOI 10.1016/j.neuint.2026.106184; online 14 May 2026). ScienceDaily ran it on 18 Oct 2026. Mice on a high-salt diet had higher blood pressure, less social interaction, and worse object-recognition memory, without a clear change in general movement or anxiety-like behavior. Adding LPC70, a soy lysolecithin in which lysophosphatidylcholine is more than 70 percent of the phospholipids, improved blood pressure, social interaction, and object memory. In kidney, the salt diet raised COX-2 and the PGE2 receptor EP3, and LPC70 reduced those rises. In prefrontal cortex, salt lowered the PGD2 receptor DP1, and LPC70 restored it without changing DP2. Tsuji Oil Mills funded the work and employs a coauthor. This is not a human trial and not a reason to start a supplement. Not medical advice. Not a substitute for a prescribed medicine.
Evidence level: Animal study. Results in animals or cells often don't carry over to people.
Read the original at Fujita Health University / Neurochemistry International
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34